Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION)
Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION)
批准号:
10729789
负责人:
Olivia Ifeoma Okereke
金额:
$73.58万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-06-30
关键词:
Academic Medical CentersAcademyAddressAffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmericanAreaAsianBehavior TherapyBehavioralBehavioral ResearchBig Data MethodsBiologicalBiological MarkersBiomedical ResearchBlack raceBostonCapsicumCaringCause of DeathCenters for Disease Control and Prevention (U.S.)Clinical TrialsCollaborationsColorCommunitiesDataData SetData SourcesDementiaDevelopmentDisciplineEducationElderlyEnsureEnvironmentEpidemiologyEquityFaceFacultyFundingGeneral HospitalsGenerationsGeriatric PsychiatryHealthHealth AllianceHealth Disparities ResearchHospitalsInequityInfrastructureInstitutionInternationalIntervention StudiesJusticeLatinoLeadershipMarketingMassachusettsMeasurementMeasuresMedicineMentorsMethodologyMethodsMinorityMinority Health ResearchModelingNeighborhoodsNew EnglandOntologyParticipantPersonsPositioning AttributePreventionPrevention approachPreventivePsychiatryQualitative MethodsRacial EquityRecordsResearchResearch PersonnelResearch TrainingResourcesSatellite HospitalsScienceScientistSiteStructural RacismSystemTestingTrainingTraining SupportTranslatingUnited States National Institutes of HealthUniversitiesVoicebehavior changebehavioral healthbehavioral health interventionclinical developmentclinical implementationclinical translationcollegecommunity cliniccommunity engaged researchcommunity engagementcommunity organizationscommunity settingdata complexitydigitaldigital healthdisabilitydisorder controleducation researcheffective interventionethnic minorityevidence basehealth disparityhealth equityhealth inequalitieshealth traininghigh riskhuman old age (65+)implementation scienceinformal careinnovationmHealthmedical schoolsmemberminority engagementnovelprogramsracial minorityrecruitsegregationskillsskills trainingsocialsocial determinantsstatisticssuccessworkforce needs
中文摘要
马萨诸塞州阿尔茨海默病和痴呆症少数民族老龄化行为研究中心(MASS-ENVISION)是一个
拟议的新的与阿尔茨海默氏症相关的少数族裔老龄化研究资源中心(AD/ADRD RCMAR)将解决
迫切需要对在医学上代表性不足(UIM)的科学家进行研究培训,
在医院和社区环境中测试和实施针对种族和民族的行为干预措施
患有阿尔茨海默病和相关疾病(ADRD)的少数老年人及其非正式护理伙伴。有一个
缺乏循证的行为干预措施来支持患有ADRD的少数族裔老年人,他们的非正式护理
合作伙伴和二人组,以及准备缓解这一短缺的UIM科学家数量的严重缺口。致信地址
这些研究和资源缺口,MassenVision将确定致力于ADRD行为的UIM科学家
健康和干预研究,并将支持独立的UIM科学家的培训和发展
消除ADRD行为健康方面的健康差距和不平等。此外,大众设想将成为唯一
RCMAR为整个新英格兰地区提供服务,该地区迫切需要这种资源。大众愿景,一种合作
马萨诸塞州综合医院(MGH)、波士顿大学(BU)和剑桥健康联盟(Cambridge Health Alliance)及其医疗机构
学校附属机构(哈佛医学院、波士顿大学医学院)、大学附属医院、其他波士顿和马萨诸塞州-
地区研究中心、卫星医院和社区诊所将为RCMAR科学家提供跨学科、
在ADRD行为健康和干预研究中使用全面的培训和持续的量身定制的指导
疾病控制中心修订的NIH阶段模型、行为改变科学和预防方法
以疾病阶段为基础(即,初级、二级、三级)和以国家医学科学院为目标(指示、
有选择的、普遍的)框架和NIA健康差异研究框架。大众设想将进行合作
与NIA资助的其他中心及其调查人员密切合作,包括马萨诸塞州阿尔茨海默病研究中心
中心(MADRC)、波士顿大学ADRC(BU-ADRC)和波士顿克劳德·D·佩珀老年美国人独立
将生物学和流行病学方面的进展转化为ADRD行为干预的机械性目标。
MASS-enVision将由UIM Pi、Okereke博士(MGH老年精神病学和MGH精神病学中心主任)领导
种族公平和正义),与团队成员和核心领导/联合领导有良好的合作记录,世卫组织
也来自不同的UIM背景(例如,黑人、亚洲人、拉丁裔、大学第一代),并具有互补性
在ADRD、健康差距和健康公平研究、社会和行为健康、行为干预、
实施科学和跨学科科学。大众设想将有4个核心:领导力和行政、
研究教育部分,数据和分析,以及社区联络和招募。核心将由以下部分组成
调查人员的背景不同,机构隶属于MA和大波士顿,学科,
以及研究和培训技能,以促进MassenVision在制定包容性研究指导方面取得成功
环境和多样化的生物医学研究队伍,以促进ADRD行为健康方面的健康公平。
英文摘要
Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg (Mass-ENVISION) is a
proposed new Alzheimer's-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) that will address
the critical need for mentored research training for underrepresented in medicine (UiM) scientists in the development,
testing, and implementation of behavioral interventions across hospital and community settings, for racial and ethnic
minority older adults with Alzheimer’s Disease and Related Disorders (ADRD) and their informal care partners. There is a
dearth of evidence-based behavioral interventions to support minority older persons with ADRD, their informal care
partners, and dyads, as well as a critical gap in the number of UiM scientists poised to mitigate this shortage. To address
these research and resource gaps, Mass-ENVISION will identify UiM scientists who are committed to ADRD behavioral
health and interventions research and will support training and development of independent UiM scientists poised to
eliminate health disparities and inequities in ADRD behavioral health. Further, Mass-ENVISION would become the only
RCMAR to serve the entire New England region, which is in critical need of this resource. Mass-ENVISION, a collaboration
of Massachusetts General Hospital (MGH), Boston University (BU) and Cambridge Health Alliance and their medical
school affiliations (Harvard Medical School, BU School of Medicine), university-affiliated hospitals, other Boston and MA-
area research centers, satellite hospitals and community clinics, will provide RCMAR Scientists with interdisciplinary,
comprehensive training and sustained and tailored mentoring in ADRD behavioral health and interventions research using
the revised NIH Stage Model, the Science of Behavior Change, prevention approaches under the Centers for Disease Control
disease stage-based (i.e., primary, secondary, tertiary) and the National Academy of Medicine target-based (indicated,
selective, universal) frameworks, and the NIA Health Disparities Research Framework. Mass-ENVISION will collaborate
closely with other NIA-funded Centers and their investigators, including the Massachusetts Alzheimer’s Disease Research
Center (MADRC), Boston University ADRC (BU-ADRC) and Boston Claude D. Pepper Older Americans Independence
Center, to translate biological and epidemiological advances as mechanistic targets for ADRD behavioral interventions.
Mass-ENVISION will be led by a UiM PI, Dr. Okereke (Director, MGH Geriatric Psychiatry and MGH Psychiatry Center
for Racial Equity and Justice), with strong collaborative track records with team members and Core Leads/Co-Leads, who
are also from diverse and UiM backgrounds (e.g., Black, Asian, Latino, first generation at college) and have complementary
expertise in ADRD, health disparities and health equity research, social and behavioral health, behavioral interventions,
implementation science, and interdisciplinary science. Mass-ENVISION will have 4 Cores: Leadership and Administrative,
Research Education Component, Data and Analysis, and Community Liaison and Recruitment. Cores will be composed of
investigators who are diverse with respect to backgrounds, institutional affiliations in MA and Greater Boston, disciplines,
and research and training skills, to facilitate Mass-ENVISION’s success in developing an inclusive research mentoring
environment and a diverse biomedical research workforce to advance health equity in ADRD behavioral health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leadership and Administrative Core (LAC)
-
批准号:10729790
-
项目类别:
-
资助金额:$24.16万
-
财政年份:2023
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Racial and Ethnic Disparities in Depression Care Utilization and Adherence among Older Adults
-
批准号:9495217
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2017
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life
-
批准号:8827198
-
项目类别:
-
资助金额:$60.11万
-
财政年份:2013
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life
-
批准号:9039154
-
项目类别:
-
资助金额:$40.23万
-
财政年份:2013
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life
-
批准号:8501935
-
项目类别:
-
资助金额:$44.06万
-
财政年份:2013
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life
-
批准号:8641418
-
项目类别:
-
资助金额:$44.19万
-
财政年份:2013
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Novel Associations of Anxiety, Depression and Telomeres across Mid- and Late-Life
-
批准号:8838908
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2013
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
-
批准号:8287716
-
项目类别:
-
资助金额:$46.86万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
-
批准号:8990077
-
项目类别:
-
资助金额:$85.29万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
-
批准号:8050351
-
项目类别:
-
资助金额:$49.03万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
-
批准号:8488478
-
项目类别:
-
资助金额:$44.41万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
-
批准号:8677974
-
项目类别:
-
资助金额:$46.16万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
-
批准号:8151083
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
VITAL-DEP (VITamin D and OmegA 3 TriaL-Depression Endpoint Prevention)
-
批准号:10512847
-
项目类别:
-
资助金额:$129.74万
-
财政年份:2010
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline
-
批准号:7530476
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2008
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline
-
批准号:7678956
-
项目类别:
-
资助金额:$13.26万
-
财政年份:2008
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline
-
批准号:8132281
-
项目类别:
-
资助金额:$13.34万
-
财政年份:2008
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
Dietary Fat Composition, Plasma Lipids, and Cognitive Decline
-
批准号:7916666
-
项目类别:
-
资助金额:$13.34万
-
财政年份:2008
-
负责人:Olivia Ifeoma Okereke
-
依托单位:
海外基金